Cargando…
Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
BACKGROUND: Lung fibroproliferation in ARDS patients is associated with mortality. Alveolar procollagen III (NT-PCP-III) is a validated biomarker of lung fibroproliferation. A chest CT scan could be useful for the diagnosis of lung fibroproliferation. The aim of this study was to identify lung fibro...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437222/ https://www.ncbi.nlm.nih.gov/pubmed/30919111 http://dx.doi.org/10.1186/s13613-019-0516-9 |
_version_ | 1783406920876425216 |
---|---|
author | Hamon, Annabelle Scemama, Ugo Bourenne, Jérémy Daviet, Florence Coiffard, Benjamin Persico, Nicolas Adda, Mélanie Guervilly, Christophe Hraiech, Sami Chaumoitre, Kathia Roch, Antoine Papazian, Laurent Forel, Jean-Marie |
author_facet | Hamon, Annabelle Scemama, Ugo Bourenne, Jérémy Daviet, Florence Coiffard, Benjamin Persico, Nicolas Adda, Mélanie Guervilly, Christophe Hraiech, Sami Chaumoitre, Kathia Roch, Antoine Papazian, Laurent Forel, Jean-Marie |
author_sort | Hamon, Annabelle |
collection | PubMed |
description | BACKGROUND: Lung fibroproliferation in ARDS patients is associated with mortality. Alveolar procollagen III (NT-PCP-III) is a validated biomarker of lung fibroproliferation. A chest CT scan could be useful for the diagnosis of lung fibroproliferation. The aim of this study was to identify lung fibroproliferative CT scan aspects in ARDS patients with high levels of NT-PCP-III. RESULTS: This retrospective study included ARDS patients who had at least one assessment of alveolar NT-PCP-III and a chest CT scan within 3 days before or after NT-PCP-III determination. An alveolar level of NT-PCP-III > 9 µG/L indicated fibroproliferation. The CT scan was scored on interstitial and alveolar abnormalities. Each lobe was scored from 0 to 5 according to the severity of the abnormalities. The crude score and the corrected score (related to the number of scored lobes in cases of important lobar condensation or lobectomy) were used. One hundred ninety-two patients were included, for a total of 228 alveolar NT-PCP-III level and CT scan ‘couples’. Crude and corrected CT scan fibrosis scores were higher in the fibroproliferation group compared with the no fibroproliferation group (crude score: 12 [9–17] vs 14 [11–12], p = 0.002; corrected score: 2.8 [2.2–4.0] vs 3.4 [2.5–4.7], p < 0.001). CT scan fibrosis scores and NT-PCP-III levels were significantly but weakly correlated (crude score: ρ = 0.178, p = 0.007; corrected score: ρ = 0.184, p = 0.005). CONCLUSIONS: When the alveolar level of NT-PCP-III was used as a surrogate marker of histological lung fibroproliferation, the CT scan fibrosis score was significantly higher in patients with active lung fibroproliferation. Pulmonary condensation is the main limitation to diagnosing fibroproliferation during ARDS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13613-019-0516-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6437222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-64372222019-04-15 Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome Hamon, Annabelle Scemama, Ugo Bourenne, Jérémy Daviet, Florence Coiffard, Benjamin Persico, Nicolas Adda, Mélanie Guervilly, Christophe Hraiech, Sami Chaumoitre, Kathia Roch, Antoine Papazian, Laurent Forel, Jean-Marie Ann Intensive Care Research BACKGROUND: Lung fibroproliferation in ARDS patients is associated with mortality. Alveolar procollagen III (NT-PCP-III) is a validated biomarker of lung fibroproliferation. A chest CT scan could be useful for the diagnosis of lung fibroproliferation. The aim of this study was to identify lung fibroproliferative CT scan aspects in ARDS patients with high levels of NT-PCP-III. RESULTS: This retrospective study included ARDS patients who had at least one assessment of alveolar NT-PCP-III and a chest CT scan within 3 days before or after NT-PCP-III determination. An alveolar level of NT-PCP-III > 9 µG/L indicated fibroproliferation. The CT scan was scored on interstitial and alveolar abnormalities. Each lobe was scored from 0 to 5 according to the severity of the abnormalities. The crude score and the corrected score (related to the number of scored lobes in cases of important lobar condensation or lobectomy) were used. One hundred ninety-two patients were included, for a total of 228 alveolar NT-PCP-III level and CT scan ‘couples’. Crude and corrected CT scan fibrosis scores were higher in the fibroproliferation group compared with the no fibroproliferation group (crude score: 12 [9–17] vs 14 [11–12], p = 0.002; corrected score: 2.8 [2.2–4.0] vs 3.4 [2.5–4.7], p < 0.001). CT scan fibrosis scores and NT-PCP-III levels were significantly but weakly correlated (crude score: ρ = 0.178, p = 0.007; corrected score: ρ = 0.184, p = 0.005). CONCLUSIONS: When the alveolar level of NT-PCP-III was used as a surrogate marker of histological lung fibroproliferation, the CT scan fibrosis score was significantly higher in patients with active lung fibroproliferation. Pulmonary condensation is the main limitation to diagnosing fibroproliferation during ARDS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13613-019-0516-9) contains supplementary material, which is available to authorized users. Springer International Publishing 2019-03-27 /pmc/articles/PMC6437222/ /pubmed/30919111 http://dx.doi.org/10.1186/s13613-019-0516-9 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Hamon, Annabelle Scemama, Ugo Bourenne, Jérémy Daviet, Florence Coiffard, Benjamin Persico, Nicolas Adda, Mélanie Guervilly, Christophe Hraiech, Sami Chaumoitre, Kathia Roch, Antoine Papazian, Laurent Forel, Jean-Marie Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome |
title | Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome |
title_full | Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome |
title_fullStr | Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome |
title_full_unstemmed | Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome |
title_short | Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome |
title_sort | chest ct scan and alveolar procollagen iii to predict lung fibroproliferation in acute respiratory distress syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437222/ https://www.ncbi.nlm.nih.gov/pubmed/30919111 http://dx.doi.org/10.1186/s13613-019-0516-9 |
work_keys_str_mv | AT hamonannabelle chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT scemamaugo chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT bourennejeremy chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT davietflorence chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT coiffardbenjamin chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT persiconicolas chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT addamelanie chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT guervillychristophe chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT hraiechsami chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT chaumoitrekathia chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT rochantoine chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT papazianlaurent chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome AT foreljeanmarie chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome |